Constitutive DUSP2 expression enhances lymphoid cell proliferation by activating CDK1 and promotes lymphomagenesis

Yu Qian1, Jutatip Panaampon1, Bjoern Chapuy2

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.

Cell Reports
|July 10, 2026
PubMed

Insights

Dual-specificity phosphatase 2 (DUSP2) unexpectedly drives lymphoid malignancies by promoting cell cycle progression. Inhibiting DUSP2 may offer a novel therapeutic strategy for these cancers.

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • Dual-specificity phosphatase 2 (DUSP2) is a nuclear phosphatase primarily found in immune cells.
  • Its expression increases with immune cell stimulation and is linked to differentiation and function.
  • The role of DUSP2 in immune cell proliferation and hematologic cancers remains unclear.

Purpose of the Study:

  • To investigate the role of DUSP2 in immune cell proliferation and hematologic malignancies.
  • To elucidate the underlying mechanisms by which DUSP2 influences cell cycle progression and cancer development.

Main Methods:

  • Analysis of DUSP2 expression in human hematologic malignancies.
  • Gene silencing of DUSP2 in lymphoma cell lines.
  • Transgenic mouse models with altered DUSP2 expression.
  • Biochemical assays to determine DUSP2's interaction with cell cycle regulators.

Main Results:

  • DUSP2 is highly expressed in various human hematologic malignancies, including B-cell and T-cell lymphomas.
  • Reducing DUSP2 levels in lymphoma cells inhibits their growth and viability.
  • Elevated DUSP2 expression in mice enhances B-cell and T-cell proliferation and promotes malignant transformation.
  • DUSP2 activates CDK1 by recruiting CDC25 phosphatases, independent of its own catalytic activity, thus promoting cell cycle progression.

Conclusions:

  • DUSP2 plays an unexpected oncogenic role in lymphoid malignancies.
  • A structural motif in DUSP2, rather than its phosphatase activity, mediates cell cycle activation.
  • DUSP2 represents a potential therapeutic target for treating hematologic cancers.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...